1 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424. 2 Tanoue LT,Tanner NT,Gould MK,et al.lung cancer screening:the balance between harm and benefit[J].Am J Respir Crit Care Med,2015,191(10):1209-1210. 3 张卉,张树才.肺癌筛查方法现状[J].中国肺癌杂志,2016,19(10):715-720. 4 Tan HT,Low J,Lim SG.Serum autoantibodies as biomarkers for early cancer detection[J].FEBS J,2009,276(23):6880-6904. 5 National Lung Screening Trial Research Team,Aberle D R,Berg C D,et al.The National Lung Screening Trial:overview and study design[J].Radiology,2011,258(1):243-253. 6 van Klaveren RJ,Oudkerk M,Prokop M,et al.Management of lung nodules detected by volume CT scanning[J].N Engl J Med,2009,361(23):2221-2229. 7 Tang ZM,Ling ZG,Wang CM,et al.Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer:a systematic review and meta-analysis[J].PLoS One,2017,12(7) :2117-2124. 8 Nesterova M,Johnson N,Cheadle C,et al.Autoantibody biomarker opens a new gateway for cancer diagnosis[J]. Biochim Biophys Acta,2006,1762(4):398-403. 9 Ren S,Zhang S,Jiang T,et al.Early detection of lung cancer by using an autoantibody panel in Chinese population[J].Oncoimmunology,2018,7(2):e1384108. 10 赵娟,刘宁,郭婧婧,等.7种肿瘤相关抗原自身抗体检测在肺癌诊断中的意义[J].临床检验杂志,2017,35(5):326-329. 11 Zhu J,Li W,Zhou J,et al.The diagnostic value of narrow-band imaging for early and invasive lung cancer:a meta-analysis[J].Clinics (Sao Paulo),2017,72(7):438-448. 12 时广利,张鑫桐,尹颜军,等.非小细胞肺癌患者肺癌自身抗体检测的临床意义[J].结核病与胸部肿瘤,2018(2):132-134. 13 Chapman CJ,Murray A,McElveen JE,et al.Autoantibodies in lung cancer:possibilities for early detection and subsequent cure[J].Thorax,2008,63(3):228-233. 14 寿伟臻. 肺结节大小与癌变的关系[J].家庭用药,2018(9):27. |